Clinical Trials Logo
  1. Home
  2. Hyperparathyroidism, Secondary
  3. NCT02464072

Subtotal Parathyroidectomy or Total Parathyroidectomy With Autograft in Chronic Kidney Disease Patients Under Dialysis

Hyperparathyroidism, Secondary Clinical Trial

Official title:
Randomized Clinical Trial of Subtotal Parathyroidectomy or Total Parathyroidectomy With Immediate Heterotopic Autograft in Chronic Renal Disease Patients Stage V Under Dialysis

Clinical Trial Summary

This study evaluates the metabolic and clinical results of two well recognized and accepted surgical techniques in the management of severe hyperparathyroidism in patients under regular dialysis treatment.

Clinical Trial Description

Prospective randomized trial in the surgical management of severe hyperparathyroidism of chronic kidney disease stage V under dialysis. Patients will be randomized and they will be submitted to subtotal parathyroidectomy or total parathyroidectomy with immediate heterotopic autograft of 45 or 90 fragments of parathyroid tissue. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02464072
Study type Interventional
Source University of Sao Paulo General Hospital
Contact
Status Active, not recruiting
Phase N/A
Start date July 2012
Completion date January 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT01134562 - Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism Phase 1
Completed NCT02523209 - Analysis of Bone Microarchitecture With HR-pQCT of Patients With Chronic Kidney Disease (CKD) Candidates for Renal Transplantation N/A
Completed NCT01922843 - A Phase 2 Study of an Oral Vitamin D Compound (DP001) in Secondary Hyperparathyroidism in Patients on Hemodialysis Phase 2
Completed NCT01651000 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3
Completed NCT00528788 - How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis Phase 4
Completed NCT01181531 - Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis Phase 4
Completed NCT05382988 - Sodium Zirconium Cyclosilicate Lowers Hyperkalemia After Parathyroidectomy Phase 3
Completed NCT02056730 - The Study of Efficacy and Safety of REGPARA Drug in Dialysis Patients Have High Blood Levels of Parathyroid Phase 4
Completed NCT01704079 - Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D Insufficiency Phase 3
Completed NCT00397475 - Evaluation of Colecalciferol Substitution in Dialysis Patients N/A
Withdrawn NCT03063190 - Cholecalciferol Supplementation in Restless Leg Syndrome in Patients With Chronic Kidney Disease Phase 4
Completed NCT02102204 - Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on Hemodialysis Phase 3
Recruiting NCT02273570 - Optimal Anemia Treatment in End Stage Renal Disease (ERSD) N/A
Completed NCT01785849 - Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on Hemodialysis Phase 3
Completed NCT01788046 - Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Phase 3
Terminated NCT01277510 - Pediatric Chronic Kidney Disease Safety and Efficacy Phase 3
Terminated NCT01439867 - Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism Phase 2
Completed NCT01134549 - Safety, Tolerability and Pharmacokinetics of KAI-4169 in Healthy Male Volunteers Phase 1
Completed NCT01785875 - Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis Phase 3
Completed NCT01290029 - Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease Phase 1